NJSの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/02/03 | 1,985 | 1,991 | 1,965 | 1,965 | -30 | -1.5% | 5,200 |
2022/02/02 | 1,995 | 1,995 | 1,987 | 1,995 | +17 | +0.9% | 2,300 |
2022/02/01 | 1,988 | 1,997 | 1,969 | 1,978 | +2 | +0.1% | 2,800 |
2022/01/31 | 1,965 | 1,982 | 1,965 | 1,976 | +10 | +0.5% | 5,200 |
2022/01/28 | 1,965 | 1,980 | 1,965 | 1,966 | +1 | +0.1% | 3,100 |
2022/01/27 | 1,974 | 1,987 | 1,965 | 1,965 | -10 | -0.5% | 5,400 |
2022/01/26 | 1,980 | 1,986 | 1,975 | 1,975 | ±0 | ±0% | 3,400 |
2022/01/25 | 1,998 | 1,998 | 1,965 | 1,975 | +17 | +0.9% | 4,700 |
2022/01/24 | 1,955 | 1,958 | 1,948 | 1,958 | +1 | +0.1% | 2,900 |
2022/01/21 | 1,944 | 1,957 | 1,944 | 1,957 | +12 | +0.6% | 1,800 |
2022/01/20 | 1,959 | 1,960 | 1,945 | 1,945 | +10 | +0.5% | 5,700 |
2022/01/19 | 1,935 | 1,944 | 1,935 | 1,935 | +4 | +0.2% | 5,700 |
2022/01/18 | 1,950 | 1,960 | 1,931 | 1,931 | -19 | -1% | 7,200 |
2022/01/17 | 1,945 | 1,950 | 1,930 | 1,950 | +28 | +1.5% | 6,800 |
2022/01/14 | 1,916 | 1,922 | 1,910 | 1,922 | +9 | +0.5% | 2,600 |
2022/01/13 | 1,911 | 1,919 | 1,911 | 1,913 | ±0 | ±0% | 1,200 |
2022/01/12 | 1,925 | 1,925 | 1,911 | 1,913 | +1 | +0.1% | 2,700 |
2022/01/11 | 1,915 | 1,915 | 1,907 | 1,912 | +4 | +0.2% | 3,800 |
2022/01/07 | 1,906 | 1,930 | 1,906 | 1,908 | +2 | +0.1% | 5,200 |
2022/01/06 | 1,907 | 1,921 | 1,906 | 1,906 | -12 | -0.6% | 2,600 |
2022/01/05 | 1,927 | 1,927 | 1,895 | 1,918 | -9 | -0.5% | 7,300 |
2022/01/04 | 1,941 | 1,941 | 1,920 | 1,927 | -7 | -0.4% | 5,100 |
2021/12/30 | 1,937 | 1,937 | 1,924 | 1,934 | -3 | -0.2% | 1,700 |
2021/12/29 | 1,938 | 1,940 | 1,912 | 1,937 | -14 | -0.7% | 6,600 |
2021/12/28 | 1,940 | 1,954 | 1,932 | 1,951 | +8 | +0.4% | 4,400 |
2021/12/27 | 1,960 | 1,960 | 1,926 | 1,943 | +23 | +1.2% | 3,800 |
2021/12/24 | 1,911 | 1,924 | 1,911 | 1,920 | +4 | +0.2% | 2,900 |
2021/12/23 | 1,920 | 1,934 | 1,906 | 1,916 | +8 | +0.4% | 2,600 |
2021/12/22 | 1,939 | 1,939 | 1,908 | 1,908 | +6 | +0.3% | 15,700 |
2021/12/21 | 1,910 | 1,910 | 1,886 | 1,902 | +29 | +1.5% | 5,200 |
2021/12/20 | 1,847 | 1,910 | 1,846 | 1,873 | +32 | +1.7% | 12,700 |
2021/12/17 | 1,848 | 1,857 | 1,841 | 1,841 | +1 | +0.1% | 4,400 |
2021/12/16 | 1,835 | 1,847 | 1,835 | 1,840 | +5 | +0.3% | 3,400 |
2021/12/15 | 1,848 | 1,863 | 1,835 | 1,835 | -3 | -0.2% | 8,300 |
2021/12/14 | 1,878 | 1,878 | 1,832 | 1,838 | -34 | -1.8% | 11,100 |
2021/12/13 | 1,873 | 1,884 | 1,851 | 1,872 | -1 | -0.1% | 10,800 |
2021/12/10 | 1,907 | 1,908 | 1,872 | 1,873 | -34 | -1.8% | 12,600 |
2021/12/09 | 1,907 | 1,917 | 1,894 | 1,907 | -10 | -0.5% | 9,700 |
2021/12/08 | 1,947 | 1,947 | 1,903 | 1,917 | -25 | -1.3% | 6,200 |
2021/12/07 | 1,937 | 1,945 | 1,899 | 1,942 | +23 | +1.2% | 7,600 |
2021/12/06 | 1,935 | 1,935 | 1,900 | 1,919 | ±0 | ±0% | 5,900 |
2021/12/03 | 1,896 | 1,946 | 1,890 | 1,919 | +19 | +1% | 9,000 |
2021/12/02 | 1,942 | 1,954 | 1,900 | 1,900 | -32 | -1.7% | 14,700 |
2021/12/01 | 1,921 | 1,982 | 1,920 | 1,932 | -11 | -0.6% | 9,700 |
2021/11/30 | 1,957 | 1,957 | 1,926 | 1,943 | +26 | +1.4% | 8,900 |
2021/11/29 | 1,972 | 1,980 | 1,914 | 1,917 | -56 | -2.8% | 6,600 |
2021/11/26 | 1,975 | 1,984 | 1,973 | 1,973 | -12 | -0.6% | 3,900 |
2021/11/25 | 1,994 | 1,996 | 1,974 | 1,985 | +10 | +0.5% | 4,700 |
2021/11/24 | 1,978 | 1,997 | 1,975 | 1,975 | -9 | -0.5% | 7,700 |
2021/11/22 | 1,985 | 1,985 | 1,977 | 1,984 | +6 | +0.3% | 1,900 |
651~
700
件表示中 / 5391件
類似銘柄と比較する
現在ご覧いただいている「NJS」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
NJS | 342,000円 | +2.2% | +73.1% | 2.78% | 15.50倍 | 1.22倍 |
|
上下水道のコンサルタント。官公需がほとんど。調査から設計・施工監理まで一貫。海外拠点多数 |
ワールドHD | 194,800円 | +17.9% | -15.9% | 4.15% | 7.36倍 | 0.86倍 |
|
製造派遣・請負が主力。技術者・研究者派遣や大都市で土地・マンション分譲も。配当性向3割 |
シーティーエス | 82,600円 | +8.2% | +5.9% | 3.03% | 17.50倍 | 2.83倍 |
|
建設ICTの専門会社。現場向けITインフラ、測量計測機器軸に全国展開。配当は業績に連動 |
WDB | 171,000円 | +5.1% | -13.4% | 3.54% | 11.31倍 | 1.12倍 |
|
理学系研究職や研究補助職の人材派遣で首位。医薬品開発受託(CRO)や医薬関連事務も |
アイロムG | 277,500円 | - | - | - | - | 2.63倍 |
|
SMO(医療機関向け治験支援)主力。日・豪でCRO(医薬品開発受託)。MBO実施準備 |
市場注目の銘柄
チャート関連のコラム